New Opportunities and Challenges to Defeat Cancer Stem Cells

Erika K. Ramos, Andrew D. Hoffmann, Stanton L. Gerson, Huiping Liu

Research output: Contribution to journalReview articlepeer-review

38 Scopus citations

Abstract

Cancer stem cells (CSCs) are a subpopulation of cancer cells that are capable of self-renewal, proliferation, differentiation, plastic adaptation, and immune regulation, thereby mediating tumorigenesis, metastasis, and therapy resistance. CSCs are associated with cancer progression and clinical outcome in cancer patients. Successful targeting of CSCs will therefore be necessary to eradicate and cure cancer. Functional regulators of stem cell (stemness) signaling pathways in human cancers have brought new opportunities to target CSCs and reframe cancer-targeting strategies in clinical settings. However, challenges remain due to a lack of complete understanding of CSC plasticity/heterogeneity and the limited efficacy of individual stemness inhibitors in cancer treatment. In this article we review CSC signaling pathways and the current state of CSC-targeting therapeutics in combinatory treatments in clinical trials. CSCs mediate tumorigenesis, metastasis, and therapy resistance via their self-renewal, proliferation, differentiation, and immune evasion abilities. Many signaling pathways regulate CSCs, including but not limited to Notch, Hedgehog, FAK, Wnt, Nanog, and STAT, and many targeting strategies have been developed to inhibit such stemness signaling. In addition to conventional and targeted therapies, immunotherapy shows promising potential in killing CSCs. Super computation-based data sharing and artificial intelligence will assist the full understanding of CSC heterogeneity, evolution, plasticity, and motility for breakthrough discoveries and the eradication of CSCs and cancer.

Original languageEnglish (US)
Pages (from-to)780-796
Number of pages17
JournalTrends in Cancer
Volume3
Issue number11
DOIs
StatePublished - Nov 2017

Keywords

  • cancer stem cells
  • immune evasion
  • targeted therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'New Opportunities and Challenges to Defeat Cancer Stem Cells'. Together they form a unique fingerprint.

Cite this